Interdisciplinary Collaboration for Hearing Health
Tracking # 20-1239542
$99999.00
There are no ratings for this course
Learn more Educator AMERICAN PHARMACISTS ASSOCIATION
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
0202-0000-24-268-H04-P - FDA approved 55 new drugs in 2023. Twenty-eight [51%] of these new drugs received orphan drug designation because they are used in the treatment of patients with rare diseases. Five new therapeutic agents are considered in this review, the second in a two-part series of articles on new therapeutic agents approved in 2023
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
1h
General